[1] |
Mudhar HS, Rennie IG. Local conjunctival metastases from primary conjunctival melanoma: clinico-pathological correlation and implications[J]. Br J Ophthalmol, 2013, 97(1): 33-39.
|
[2] |
谭辉,毛俊峰. 结膜交接痣转化为恶性黑色素瘤一例[J]. 国际眼科杂志,2010,10(4):823.
|
[3] |
李强. 43例结膜黑色素瘤的临床和病理学特点[J]. 中国医药指南,2013,11(19):437-438.
|
[4] |
Milman T, Zhang Q, Ang S, et al. Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67[J]. Hum Pathol, 2020, 103: 107-119.
|
[5] |
Kiyohara T, Tanimura H, Miyamoto M, et al. Two cases of BRAF-mutated, bulbar conjunctival melanoma, and review of the published literature[J]. Clin Exp Dermatol, 2020, 45(2): 207-211.
|
[6] |
Kim HK, Chae SW, Woo KI, et al. Expression of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of MMP (TIMP)-1 in conjunctival melanomas and clinical implications[J]. Jpn J Ophthalmol, 2010, 54(3): 221-226.
|
[7] |
Balzer BWR, Cherepanoff S, Joshua AM, et al. Conjunctival melanoma in childhood and adolescence: a systematic review[J]. Ocul Oncol Pathol, 2019, 5(6): 387-395.
|
[8] |
Maschi-Cayla C, Doyen J, Gastaud P, et al. Conjunctival melanomas and proton beam therapy[J]. Acta Ophthalmol, 2013, 91(8): e647.
|
[9] |
石安杰,杨玉琼,李佳,等.局部切除术联合冷冻治疗结膜恶性黑色素瘤生存率分析[J].重庆医学,2021,50(13):2269-2273,2282.
|
[10] |
Kaliki S, Vasanthapuram VH, Mishra DK. Conjunctival melano-ma in Asian Indians: a study of 42 patients[J]. Semin Ophthalmol, 2019, 34(3): 182-187.
|
[11] |
Busam KJ, Fang Y, Jhanwar SC, et al. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization[J]. J Cutan Pathol, 2010, 37(2): 196-203.
|
[12] |
Zhou C, Wang Y, Jia R, et al. Conjunctival melanoma in Chinese patients: local recurrence, metastasis, mortality, and comparisons with caucasian patients[J]. Invest Ophthalmol Vis Sci, 2017, 58(12): 5452-5459.
|
[13] |
苏冠羽,梁庆丰,李彬. 睑结膜恶性黑色素瘤诊疗一例[J]. 中华实验眼科杂志,2019,37(9):724-725.
|
[14] |
Kakkassery V, Winterhalter S, Nick AC, et al. Vascular-associated muc4/vwf co-localization in human conjunctival malignant melanoma specimens-tumor metastasis by migration?[J]. Curr Eye Res, 2017, 42(10): 1382-1388.
|
[15] |
Li Y, Fan X, Jia R. Conjunctival melanoma: update on management[J]. Int Ophthalmol Clin, 2019, 59(2): 27-35.
|
[16] |
徐芳,张红岩. 结膜黑色素瘤的临床和病理学特点[J]. 科技资讯,2015,12(10):232.
|
[17] |
Chen PY, Liao YL, Chu YC, et al. Conjunctival melanoma: A 20-year survey in a comprehensive medical center[J]. J Formos Med Assoc, 2021, 120(1): 250-255.
|
[18] |
Jain P, Finger PT, Fili M, et al. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study[J]. Br J Ophthalmol, 2021, 105(10): 1358-1364.
|
[19] |
Pinto-Proença R, Santos M, Fonseca C, et al. Conjunctival melanoma: association of cyclooxygenase-2 tumor expression to prognosis[J]. Graefes Arch Clin Exp Ophthalmol, 2018, 256(5): 989-995.
|
[20] |
Shildkrot Y, Wilson MW. Conjunctival melanoma: pitfalls and dilemmas in management[J]. Curr Opin Ophthalmol, 2010, 21(5): 380-386.
|
[21] |
Kaštelan S, Gveroviĉ AA, Beketiĉ OL, et al. Conjunctival melanoma--epidemiological trends and features[J]. Pathol Oncol Res, 2018, 24(4): 787-796.
|
[22] |
Fasina O, Oluwasola OA. Conjunctival melanoma in South-western Nigeria: a case series and review of literature[J]. Int Ophthalmol, 2018, 38(4): 1747-1752.
|
[23] |
Park SJ, Oh CM, Kim BW, et al. Nationwide incidence of ocular melanoma in South Korea by using the national cancer registry database (1999-2011) [J]. Invest Ophthalmol Vis Sci, 2015, 56(8): 4719-4724.
|
[24] |
Triay E, Bergman L, Nilsson B, et al. Time trends in the incidence of conjunctival melanoma in Sweden[J]. Br J Ophthalmol, 2009, 93(11): 1524-1528.
|
[25] |
Yu GP, Hu DN, McCormick S, et al. Conjunctival melanoma: is it increasing in the United States? [J]. Am J Ophthalmol, 2003, 135(6): 800-806.
|
[26] |
Brouwer NJ, Marinkovic M, Luyten GPM, et al. Pigmentation of conjunctival melanoma recurrences and outcome[J]. Graefes Arch Clin Exp Ophthalmol, 2019, 257(8): 1783-1788.
|
[27] |
江志坚,张辉,董健鸿. 眶内容物剜除治疗结膜恶性黑色素瘤16例分析[J]. 中国实用眼科杂志,2015,33(10):1170-1172.
|
[28] |
Blum ES, Yang J, Komatsubara KM, et al. Clinical management of uveal and conjunctival melanoma[J]. Oncology (Williston Park), 2016, 30(1): 29-32, 34-43, 48.
|
[29] |
He F, Wang Y, Jia R. Conjunctival melanoma metastasis to the contralateral Orbit[J]. J Craniofac Surg, 2018, 29(8): 2128-2130.
|
[30] |
Cohen VML, Tsimpida M, Hungerford JL, et al. Prospective study of sentinel lymph node biopsy for conjunctival melanoma[J]. Br J Ophthalmol, 2013, 97(12): 1525-1529.
|
[31] |
Tatla T, Hungerford J, Plowman N, et al. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease[J]. Laryngoscope, 2005, 115(5): 817-822.
|
[32] |
林锦镛,刘冬,李恩江. 26例结膜黑色素瘤的临床和病理学特点[J]. 中华眼科杂志,2010,46(4):308-311.
|
[33] |
邹海兰,孙巍巍,白华,等. 结膜原发性获得性黑变病恶变1例[J]. 诊断病理学杂志,2010,17(2):157.
|
[34] |
Brownstein S. Malignant melanoma of the conjunctiva[J]. Cancer Control, 2004, 11(5): 310-316.
|
[35] |
Larsen AC. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile[J]. Acta Ophthalmol, 2016, 94(1): 1-27.
|
[36] |
Ho VH, Prager TC, Diwan H, et al. Ultrasound biomicroscopy for estimation of tumor thickness for conjunctival melanoma[J]. J Clin Ultrasound, 2007, 35(9): 533-537.
|
[37] |
Shields CL, Markowitz JS, Belinsky I, et al. Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases[J]. Ophthalmology, 2011, 118(2): 389-395.
|
[38] |
Harooni H, Schoenfield LR, Singh AD. Current appraisal of conjunctival melanocytic tumors: classification and treatment[J]. Future Oncol, 2011, 7(3): 435-446.
|
[39] |
黄胜,任永丰. 结膜恶性黑色素瘤17例临床分析[J]. 眼科新进展,2009,22(3):216-218.
|
[40] |
Rajbhandari Y, Gupta S, Yadav R, et al. A rare case of conjunctival malignant melanoma with orbital invasion[J]. Nepal J Ophthalmol, 2019, 11(1): 77-81.
|
[41] |
Grimes JM, Shah NV, Samie FH, et al. Conjunctival melanoma: current treatments and future options[J]. Am J Clin Dermatol, 2020, 21(3): 371-381.
|
[42] |
申发燕,张海萍,钟山,等. 结膜恶性黑色素瘤3例临床病理分析及文献复习[J]. 中国组织化学与细胞化学杂志,2018,27(6): 559-564.
|
[43] |
Reddy HS, Keene CD, Chang SH, et al. Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions[J]. Exp Mol Pathol, 2017, 102(2): 198-202.
|
[44] |
陈雪,张培,郭建新,等. 结膜色素痣和黑色素瘤的免疫组织化学特点分析[J]. 中华实验眼科杂志,2012,30(2):191-192.
|
[45] |
Esmaeli B. Regional lymph node assessment for conjunctival melanoma: sentinel lymph node biopsy and positron emission tomography[J]. Br J Ophthalmol, 2008, 92(4): 443-445.
|
[46] |
Damato B, Coupland SE. Clinical mapping of conjunctival melanomas[J]. Br J Ophthalmol, 2008, 92(11): 1545-1549.
|
[47] |
Shields CL, Chien JL, Surakiatchanukul T, et al. Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes[J]. Asia Pac J Ophthalmol (Phila), 2017, 6(2): 109-120.
|
[48] |
Chaves LJ, Huth B, Augsburger JJ, et al. Eye-sparing treatment for diffuse invasive conjunctival melanoma[J]. Ocul Oncol Pathol, 2018, 4(4): 261-266.
|
[49] |
Werschnik C, Lommatzsch PK. Long-term follow-up of patients with conjunctival melanoma[J]. Am J Clin Oncol, 2002, 25(3): 248-255.
|
[50] |
Stacy RC, Kenyon KR, Jakobiec FA, et al. Conjunctival melanoma arising from primary acquired melanosis in a patient with neurofibromatosis type I[J]. Cornea, 2010, 29(2): 232-234.
|
[51] |
Wuestemeyer H, Sauerwein W, Meller D, et al. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma[J]. Graefes Arch Clin Exp Ophthalmol, 2005, 244(4): 438-446.
|
[52] |
Brouwer NJ, Marinkovic M, van-Duinen SG, et al. Treatment of conjunctival melanoma in a Dutch referral centre[J]. Br J Ophthalmol, 2018, 102(9): 1277-1282.
|
[53] |
Finger PT, Pavlick AC. Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series[J]. J Immunother Cancer, 2019, 7(1): 83.
|
[54] |
Wierenga APA, Cao J, Luyten GPM, et al. Immune checkpoint inhibitors in uveal and conjunctival melanoma[J]. Int Ophthalmol Clin, 2019, 59(2): 53-63.
|
[55] |
Kiyohara T, Tanimura H, Miyamoto M, et al. Two cases of BRAF-mutated, bulbar conjunctival melanoma, and review of the published literature[J]. Clin Exp Dermatol, 2020, 45(2): 207-211.
|
[56] |
Scholz SL, Hérault J, Stang A, et al. Proton radiotherapy in advanced malignant melanoma of the conjunctiva[J]. Graefes Arch Clin Exp Ophthalmol, 2019, 257(6): 1309-1318.
|